|1.||Miyoshi, Eiji: 22 articles (08/2015 - 01/2004)|
|2.||Taniguchi, Naoyuki: 12 articles (07/2011 - 01/2004)|
|3.||Kim, Yong-Sam: 7 articles (02/2013 - 01/2008)|
|4.||Yoo, Jong Shin: 5 articles (09/2012 - 01/2008)|
|5.||Ko, Jeong-Heon: 4 articles (02/2013 - 01/2008)|
|6.||Guo, Hua-Bei: 4 articles (12/2009 - 12/2002)|
|7.||Pierce, Michael: 4 articles (12/2009 - 12/2002)|
|8.||Kondo, Akihiro: 4 articles (10/2006 - 05/2005)|
|9.||Nakagawa, Takatoshi: 4 articles (10/2006 - 05/2005)|
|10.||Terao, Mika: 3 articles (08/2015 - 07/2012)|
01/01/2011 - "Accumulating evidence indicate that N-acetylglucosaminyltransferase V (Mgat5 or GnT-V) is involved in cancer development. "
01/01/2010 - "N-acetylglucosaminyltransferase V (GnT-V) has been reported to be positively associated with tumor progression, but its mechanism still remains unknown. "
11/01/2009 - "High expression of N-acetylglucosaminyltransferase V in mucinous tumors of the ovary."
06/01/2009 - "N-acetylglucosaminyltransferase-V (GnT-V) has been reported to be closely associated with tumor migration, but the mechanism has been not currently clear. "
11/28/2008 - "In some cancer cells, an increase of beta1,6-GlcNAc catalyzed by N-acetylglucosaminyltransferase V (GnT-V) is related to the promotion of cancer cell motility. "
08/05/1999 - "Expression of N-acetylglucosaminyltransferase V in gastric carcinomas was significantly enhanced compared to normal tissue. "
10/25/1996 - "Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1."
04/01/2014 - "Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder."
01/01/2005 - "Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions."
07/27/2007 - "To study in detail the mechanisms by which aberrant N-glycosylation caused by altered N-acetylglucosaminyltransferase V(GnT-V, GnT-Va, and Mgat5a) expression can regulate the invasiveness-related phenotypes found in some carcinomas, we utilized specific small interfering RNA (siRNA) to selectively knock down GnT-V expression in the highly metastatic and invasive human breast carcinoma cell line, MDA-MB231. "
|3.||Prostatic Neoplasms (Prostate Cancer)
08/29/2014 - "The purpose of this study was to investigate the relationship between N-acetylglucosaminyltransferase V (GnT-V) and radiation sensitivity of prostate cancer (PCa) cells both in vitro and in vivo. "
08/29/2014 - "Inhibition of N-acetylglucosaminyltransferase V enhances sensitivity of radiotherapy in human prostate cancer."
06/01/2010 - "To investigate the effect of short hairpin RNA (shRNA) targeting N-acetylglucosaminyltransferase V (GnT-V) on the proliferation of prostate cancer PC-3 cells. "
06/01/2010 - "[Short hairpin RNA targeting N-acetylglucosaminyltransferase V inhibits the proliferation of prostate cancer PC-3 cell line]."
07/01/2008 - "Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis."
|4.||Colonic Neoplasms (Colon Cancer)
01/01/2004 - "Attachment of human colon cancer cells to vascular endothelium is enhanced by N-acetylglucosaminyltransferase V."
01/01/2004 - "Expression of N-acetylglucosaminyltransferase V (GnT-V) in colon cancer has been shown to be related to hematogenous metastasis and poor prognosis. "
01/01/2008 - "Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1."
06/01/2010 - "For this, aberrant glycoforms of the tissue inhibitor of metalloproteinase 1 (TIMP1) and protein tyrosine phosphatase kappa (PTPkappa), previously known target proteins for N-acetylglucosaminyltransferase-V (GnT-V), were enriched by phytohemagglutinin-L(4) (L-PHA) lectin and comparatively analyzed in the conditioned medium of the WiDr colon cancer cell line and its GnT-V-overexpressing transfectant cells. "
|5.||Astrocytoma (Pilocytic Astrocytoma)
|1.||Tissue Inhibitor of Metalloproteinase-1
|2.||Small Interfering RNA (siRNA)
|3.||Complementary DNA (cDNA)
|9.||Proteins (Proteins, Gene)